Zalcitabine |
ddC; dideoxycytidine; Hivid |
Clinical Trial: A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT
This study has been completed.
|
Purpose
PRIMARY: To determine safety, tolerance, and pharmacokinetics of zidovudine (AZT) and zalcitabine (dideoxycytidine; ddC) when given in combination in clinically stable AZT-treated children. SECONDARY: To compare combination therapy with mono drug therapy for antiviral activity and laboratory markers of disease progression, as determined by virologic and immunologic determinations. To evaluate the influence of combination therapy on disease progression as determined by evaluation of clinical criteria. In children currently being treated with AZT, it is unknown whether the addition of another antiretroviral agent such as ddC would help increase efficacy and tolerance. This study will examine the possible advantages of combination AZT/ddC therapy over monotherapy with AZT alone.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| HIV Infections | Drug: Zidovudine Drug: Zalcitabine | Phase II |
MedlinePlus related topics: AIDS
Study Type: Interventional
Study Design: Treatment
Official Title: A Phase II Study to Evaluate Pharmacokinetics, Safety, Tolerance and Activity of Dideoxycytidine (ddC) Administered in Combination with Zidovudine (AZT) in Stable, AZT-Treated Pediatric Patients with HIV Infection
Expected Total Enrollment: 180
In children currently being treated with AZT, it is unknown whether the addition of another antiretroviral agent such as ddC would help increase efficacy and tolerance. This study will examine the possible advantages of combination AZT/ddC therapy over monotherapy with AZT alone.
Patients are stratified according to duration of ongoing AZT therapy and are randomized to receive AZT either alone or in combination with ddC. Patients receive therapy until the last patient enrolled completes 32 weeks of therapy. The study may be extended for two additional 32-week periods on an optional basis.
Eligibility
Ages Eligible for Study: 3 Months - 12 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria
Concurrent Medication: Recommended:
- PCP prophylaxis.
Allowed:
- Intravenous and/or intramuscular immunoglobulin.
- Acyclovir (no more than 30 mg/kg/day PO).
- Ketoconazole (no more than 10 mg/kg/day).
- Nystatin.
- Aspirin, acetaminophen, nonsteroidal anti-inflammatory drugs, sedatives, and barbiturates, not to exceed 72 hours.
- Isoniazid in combination with pyridoxine, provided there is no evidence of peripheral neuropathy.
- Trimethoprim / sulfamethoxazole.
- Amphotericin B (no more than 1 mg/kg for 5 days/week).
- Aerosolized ribavirin for bronchiolitis.
- Hematopoietic agents.
- Other drugs with little nephro-, hepato-, or cytotoxicity.
- Nutritional support for HIV wasting syndrome or malnutrition.
Patients must have:
- HIV infection.
- Ongoing stable AZT therapy.
Exclusion Criteria
Co-existing Condition: Patients with the following symptoms and conditions are excluded:
- Disease progression while on AZT, to the extent that the patient meets the criteria for advanced disease protocols.
- Known allergy or sensitivity to ddC.
- Cardiomyopathy.
Concurrent Medication: Excluded:
- Biologic modifiers other than IVIG, steroids, or hematopoietic agents.
- Investigational medications unless approved by protocol chair.
- Medications known to cause pancreatitis (unless ddC is interrupted while these medications are given).
Patients with the following prior conditions are excluded:
- History of intolerance or toxicity to AZT.
- History of symptomatic pancreatitis.
- History of peripheral neuropathy or abnormal nerve conduction velocity test.
Prior Medication: Excluded:
- Antiretroviral agents other than AZT within 2 weeks of study entry.
Required:
Location Information
Alabama
Univ of Alabama at Birmingham Schl of Med / Pediatrics, Birmingham, Alabama, 35294, United States
California
UCSF / Moffitt Hosp - Pediatric, San Francisco, California, 941430105, United States
UCSD Med Ctr / Pediatrics / Clinical Sciences, La Jolla, California, 920930672, United States
San Francisco Gen Hosp, San Francisco, California, 94110, United States
Stanford Univ School of Medicine / Pediatrics, Stanford, California, 943054149, United States
Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, 905022004, United States
Children's Hosp of Oakland, Oakland, California, 946091809, United States
UCLA Med Ctr / Pediatric, Los Angeles, California, 900951752, United States
Cedars Sinai / UCLA Med Ctr, Los Angeles, California, 900481804, United States
Long Beach Memorial (Pediatric), Long Beach, California, 90801, United States
Los Angeles County - USC Med Ctr, Los Angeles, California, 90033, United States
Colorado
Children's Hosp of Denver, Denver, Colorado, 802181088, United States
Connecticut
Yale Univ Med School, New Haven, Connecticut, 06504, United States
Univ of Connecticut / Farmington, Farmington, Connecticut, 06032, United States
District of Columbia
Howard Univ Hosp, Washington, District of Columbia, 20060, United States
Children's Hosp of Washington DC, Washington, District of Columbia, 200102916, United States
Georgetown Univ Med Ctr, Washington, District of Columbia, 20007, United States
Florida
Univ of Miami (Pediatric), Miami, Florida, 33161, United States
Georgia
Emory Univ Hosp / Pediatrics, Atlanta, Georgia, 30306, United States
Illinois
Chicago Children's Memorial Hosp, Chicago, Illinois, 606143394, United States
Cook County Hosp, Chicago, Illinois, 60612, United States
Univ of Illinois College of Medicine / Pediatrics, Chicago, Illinois, 60612, United States
Univ of Chicago Children's Hosp, Chicago, Illinois, 606371470, United States
Louisiana
Tulane Univ / Charity Hosp of New Orleans, New Orleans, Louisiana, 701122699, United States
Maryland
Univ of Maryland at Baltimore / Univ Med Ctr, Baltimore, Maryland, 21201, United States
Massachusetts
Children's Hosp of Boston, Boston, Massachusetts, 021155724, United States
Boston City Hosp / Pediatrics, Boston, Massachusetts, 02118, United States
Baystate Med Ctr of Springfield, Springfield, Massachusetts, 01199, United States
Univ of Massachusetts Med School, Worcester, Massachusetts, 016550001, United States
Michigan
Children's Hosp of Michigan, Detroit, Michigan, 48201, United States
New Jersey
Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl, Newark, New Jersey, 071072198, United States
Saint Joseph's Hosp and Med Ctr/UMDNJ - New Jersey Med Schl, Newark, New Jersey, 07103, United States
New York
King's County Hosp Ctr / Pediatrics, Brooklyn, New York, 11203, United States
SUNY - Brooklyn, Brooklyn, New York, 11203, United States
North Shore Univ Hosp, Great Neck, New York, 11021, United States
Westchester Hosp, Valhalla, New York, 10595, United States
Schneider Children's Hosp, New Hyde Park, New York, 11040, United States
Univ of Rochester Medical Center, Rochester, New York, 14642, United States
Bellevue Hosp / New York Univ Med Ctr, New York, New York, 10016, United States
Mount Sinai Med Ctr, New York, New York, 10029, United States
Columbia Presbyterian Med Ctr, New York, New York, 10032, United States
Mount Sinai Med Ctr / Pediatrics, New York, New York, 10029, United States
Albert Einstein College of Medicine, Bronx, New York, 10461, United States
Metropolitan Hosp Ctr, New York, New York, 10029, United States
Children's Hosp at Albany Med Ctr, Albany, New York, 12208, United States
SUNY Health Sciences Ctr at Syracuse / Pediatrics, Syracuse, New York, 13210, United States
Bronx Lebanon Hosp Ctr, Bronx, New York, 10457, United States
Incarnation Children's Ctr / Columbia Presbyterian Med Ctr, New York, New York, 10032, United States
Lincoln Hosp Ctr, Bronx, New York, 10451, United States
Children's Hosp Pact Prog / Children's Hosp of Buffalo, Buffalo, New York, 14222, United States
North Carolina
Duke Univ Med Ctr, Durham, North Carolina, 277103499, United States
Ohio
Columbus Children's Hosp, Columbus, Ohio, 432052696, United States
Pennsylvania
Children's Hosp of Philadelphia, Philadelphia, Pennsylvania, 191044318, United States
Saint Christopher's Hosp for Children, Philadelphia, Pennsylvania, 191341095, United States
Rhode Island
Rhode Island Hosp / Brown Univ, Providence, Rhode Island, 02903, United States
South Carolina
Med Univ of South Carolina, Charleston, South Carolina, 294253312, United States
Washington
Children's Hospital & Medical Center / Seattle ACTU, Seattle, Washington, 981050371, United States
Canada, Ontario
Sunnybrook Health Science Ctr, Toronto, Ontario, Canada
Puerto Rico
San Juan City Hosp, San Juan, 009367344, Puerto Rico
Univ of Puerto Rico / Univ Children's Hosp AIDS, San Juan, 009365067, Puerto Rico
Ramon Ruiz Arnau Univ Hosp / Pediatrics, Bayamon, 00956, Puerto Rico
S Pahwa, Study Chair
SS Bakshi, Study Chair
More Information
Click here for more information about Zidovudine
Click here for more information about Zalcitabine
Publications
Bakshi SS, Britto P, Capparelli E, Mofenson L, Fowler MG, Rasheed S, Schoenfeld D, Zimmer B, Frank Y, Yogev R, Jimenez E, Salgo M, Boone G, Pahwa SG. Evaluation of pharmacokinetics, safety, tolerance, and activity of combination of zalcitabine and zidovudine in stable, zidovudine-treated pediatric patients with human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 190 Team. J Infect Dis. 1997 May;175(5):1039-50.
Dankner WM, Lindsey JC, Levin MJ. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J. 2001 Jan;20(1):40-8.
Record last reviewed: May 1995
Last Updated: April 7, 2005
Record first received: November 2, 1999
ClinicalTrials.gov Identifier: NCT00001032
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


